A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators (NCT06504589)
🩺 Plain-English Summary (8th-Grade Level)
The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to inform CF research, help design CF clinical trials and support the development of new treatments for people with CF who do not take CFTR modulators. Another goal of this study is to learn about research involvement for people with CF who do not take CFTR modulators, engage them in research, and give them an opportunity to learn about what is involved in participating in a CF research study.
Who can join: Review the eligibility criteria below.
Location: The Children's Hospital Alabama, University of Alabama at Birmingham — Birmingham, Alabama
Age range: 12 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (68 Sites)
Showing the first 25 of 68 sites.
- The Children's Hospital Alabama, University of Alabama at Birmingham — Birmingham, Alabama
- Phoenix Children's Hospital — Phoenix, Arizona
- Tucson Cystic Fibrosis Center — Tucson, Arizona
- University of Arkansas for Medical Sciences — Little Rock, Arkansas
- University of California San Diego — La Jolla, California
- Childrens Hospital Los Angeles — Los Angeles, California
- Stanford University Medical Center — Palo Alto, California
- University of California, San Francisco - Adult Center — San Francisco, California
- University of California, San Francisco - Peds Center — San Francisco, California
- Children's Hospital Colorado — Aurora, Colorado
- National Jewish Health — Denver, Colorado
- University of Florida — Gainesville, Florida
- University of Miami — Miami, Florida
- Central Florida Pulmonary Group — Orlando, Florida
- Tampa General Hospital — Tampa, Florida
- Children's Healthcare of Atlanta and Emory University — Atlanta, Georgia
- Augusta University — Augusta, Georgia
- Saint Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho
- Northwestern University — Chicago, Illinois
- Riley Hospital for Children — Indianapolis, Indiana
- University of Kansas Medical Center — Kansas City, Kansas
- University of Kentucky — Lexington, Kentucky
- Tulane University — Metairie, Louisiana
- John Hopkins Hospital — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (206) 884-1681
Email: olena.boyarska@seattlechildrens.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cystic Fibrosis
- Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease — Chapel Hill, North Carolina
- Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Orange, California
- Hyperpolarized Imaging for New Treatments — Cincinnati, Ohio
- Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI — Cincinnati, Ohio
- Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older — Nedlands,
- Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis — Cincinnati, Ohio
Explore by condition: All Cystic Fibrosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.